% | $
Quotes you view appear here for quick access.

Roche Holding AG Message Board

  • kmaggon kmaggon Jan 26, 2011 3:46 AM Flag

    Melanoma Market RG7204

    Melanoma Market
    The near future met melanoma market will be dominated by the CTLA4 mab Ipilimumab and BRAF inhibitors PLX4032. What is the market potential of melanoma vaccines like Allovectin and OncoVex and PD1 mab.
    A new section on Melanoma vaccine Allovectin and Oncovex added and get the live RSS feeds for breaking news concerning Ipilimumab. The following IPI review was submitted and accepted by the FDA for circulation to its Oncology Drug Advisory Committee experts to discuss Ipilimumab due in March 2011.
    Ipilimumab (BMS) Review: A Cancer Breakthrough?

28.36-0.26(-0.91%)Oct 26 3:59 PMEDT